Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-21-066329
Filing Date
2021-12-20
Accepted
2021-12-20 16:15:16
Documents
3
Period of Report
2022-02-08

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea151669-def14a_citiuspharma.htm DEF 14A 373742
2 GRAPHIC image_001.jpg GRAPHIC 154918
3 GRAPHIC image_002.jpg GRAPHIC 133410
  Complete submission text file 0001213900-21-066329.txt   772252
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38174 | Film No.: 211505410
SIC: 2834 Pharmaceutical Preparations